What is the current price and market status of ROG.SW stock?

ROG.SW stock trades pre‑market at **CHF335.20** on SIX with volume **1,233,331**, a day range **CHF334.00–CHF339.80**, and a PE ratio of **20.90**. Trading activity is above average today.

What are Meyka AI's short and long forecasts for ROG.SW stock?

Meyka AI's forecast model projects monthly **CHF348.23** (upside **3.89%**) and yearly **CHF251.97** (downside **-24.85%**) versus current price **CHF335.20**. Forecasts are projections and not guarantees.

What key risks should investors watch for ROG.SW stock?

Watch patent expiries, pricing pressure in major markets, pipeline readouts, and earnings surprises. Roche’s price/book is relatively high and leverage (debt/equity **0.94**) raises valuation sensitivity.

When does Roche report earnings and how could that affect ROG.SW stock?

Roche has earnings scheduled for **2026‑07‑23**. Results and guidance can shift valuation quickly; diagnostics revenue beats or misses often move the stock on SIX by several percent intraday.

CH Stocks

ROG.SW Roche Holding AG SIX pre-market CHF335.20 most active 11 Mar 2026: Volume rise signals earnings focus

ByDanny Kontos March 11, 2026March 11, 2026

ROG.SW stock opened pre-market at CHF335.20 on 11 Mar 2026 and ranks among the most active names on the SIX, trading 1,233,331 shares so far. The early move lifts the price 0.84% from the previous close and follows a steady 3‑month gain of 4.10%. Traders are positioning ahead of mid‑year results and ongoing diagnostics momentum. This pre‑market lift combines solid fundamentals with short‑term technical signals, and our coverage uses Meyka AI’s real‑time model to frame short and medium‑term scenarios.